Somerville, MA, United States of America

William Ralvenius

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Unversität Zürich, Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Ralvenius. Retrieved from https://idiyas.com/inventor/william-ralvenius

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of William Ralvenius

Introduction

William Ralvenius is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmacology, particularly in the treatment of itch through innovative compounds. With a total of 4 patents to his name, Ralvenius continues to push the boundaries of scientific research.

Latest Patents

Ralvenius's latest patents focus on the use of GABAreceptor modulators for the treatment of itch. One of his notable inventions provides a compound that comprises the general formula (1a), general formula (1b), or general formula (1c). These compounds are identified as positive allosteric α2 and/or α3 GABAreceptor modulators, showcasing his dedication to developing effective treatments for this common condition.

Career Highlights

Throughout his career, Ralvenius has been associated with Universitat Zurich, where he has collaborated with other researchers to advance the understanding of GABAreceptor modulators. His work has been instrumental in paving the way for new therapeutic approaches in treating itch.

Collaborations

Ralvenius has worked closely with Hanns Ulrich Zeilhofer, a fellow researcher, to explore the potential of GABAreceptor modulators. Their collaboration has led to significant advancements in the field.

Conclusion

William Ralvenius is a notable inventor whose work in the development of GABAreceptor modulators has the potential to transform the treatment of itch. His contributions to pharmacology and collaboration with esteemed colleagues highlight his commitment to innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…